Código QR (código de barras bidimensional)

Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study

Abstract Background OnabotulinumtoxinA (BOTOX®, Allergan plc, Dublin, Ireland) is approved for the preventive treatment of headaches in adult patients with chronic migraine (CM) in Australia by the country’s reimbursement mechanism for medicines, the Pharmaceutical Benefits Scheme (PBS). To our know...

ver descrição completa

Na minha lista:
Principais autores: Catherine Stark, Richard Stark, Nicole Limberg, Julian Rodrigues, Dennis Cordato, Raymond Schwartz, Robert Jukic
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2019-07-01
coleção:The Journal of Headache and Pain
Assuntos:
Migraine disorders
Headache
OnabotulinumtoxinA
Australia
Retrospective studies
Codeine
Acesso em linha:http://link.springer.com/article/10.1186/s10194-019-1030-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados